Related Experiment Video
Updated: May 1, 2026
09:02
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
Published on: February 20, 2021
2.4K
Characterizing viral clearance kinetics in acute influenza
Phrutsamon Wongnak1, Tim Seers1, Podjanee Jittamala1,2
1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand.
Summary
This study models natural influenza viral clearance to optimize antiviral drug trials. An exponential decay model with frequent sampling significantly reduces patient numbers needed to detect treatment effects.
Area of Science:
- Virology
- Pharmacometrics
- Clinical Trial Design
Background:
- Antiviral efficacy in acute influenza is crucial for treatment and pandemic preparedness.
- Understanding natural viral clearance kinetics is key to designing effective clinical trials.
Purpose of the Study:
- To characterize natural viral clearance in acute influenza.
- To guide phase II clinical trial design using simulations based on observed data.
- To inform pandemic preparedness strategies.
Main Methods:
- Collected daily oropharyngeal swabs from 80 untreated adults over 14 days.
- Measured viral densities using quantitative polymerase chain reaction.
- Evaluated exponential, bi-exponential, and growth-and-decay models for viral clearance.
Main Results:
- The exponential decay model was the most parsimonious fit for viral clearance.
- Median viral clearance half-life was 10.3 hours, differing between influenza A (9.6h) and B (14.0h).
- Simulations indicated 148 patients/arm needed to detect a 40% acceleration in clearance; frequent sampling reduced this to 81 patients/arm.
Conclusions:
- The exponential decay model effectively describes influenza viral clearance.
- Optimized sampling strategies and modeling can reduce sample sizes in antiviral trials.
- This approach aids in assessing and comparing anti-influenza drug efficacy.
Related Concept Videos
01:27Influenza
87
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87
01:05Elimination Kinetics: First-Order and Zero-Order
4.0K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
4.0K
01:17Clearance Models: Noncompartmental Models
367
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
367
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
497
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
497
01:17Kinetics of Drug Elimination
3.8K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
3.8K